dr. ir. A.M.G. Pasmooij

E-mail:
a.m.g.pasmooij umcg.nl

Research

Publications
  1. Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa

    Bremer, J., van der Heijden, E. H., Eichhorn, D. S., Meijer, R., Lemmink, H. H., Scheffer, H., Sinke, R. J., Jonkman, M. F., Pasmooij, A. M. G. & Van den Akker, P. C., 18-Dec-2019, In : Molecular therapy - Nucleic acids. 18, p. 465-475 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Natural exon skipping reveals that antisense oligonucleotide-mediated exon skipping should be directed at the recessive type of dystrophic epidermolysis bullosa

    Bremer, J., van der Heijden, E. H., Eichhorn, D. S., Meijer, R., Lemmink, H. H., Scheffer, H., Sinke, R. S., Jonkman, M. F., Pasmooij, A. M. G. & Van den Akker, P. C., Oct-2019, In : European Journal of Human Genetics. 27, p. 1280-1281 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. Marcel F. Jonkman, MD, PhD (1957–2019): In Memoriam

    Akker, van den, P. C., Bolling, M. C., Pasmooij, A. M. G., Kelsell, D. & Uitto, J., May-2019, In : Journal of Investigative Dermatology. 139, 5, p. 982-983 2 p.

    Research output: Contribution to journalLetterAcademic

  4. Murine type VII collagen distorts outcome in human skin graft mouse models for dystrophic epidermolysis bullosa

    Bremer, J., Kramer, D., Eichhorn, D., Escamez, M., Gostyski, A., Del Rio, M., Larcher, F., Jonkman, M. F., van den Akker, P. & Pasmooij, A., May-2018, In : Journal of Investigative Dermatology. 138, 5, p. S127 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  5. Topical Gentamicin for the Treatment of Genetic Skin Diseases

    Pasmooij, A. M. G., Apr-2018, In : Journal of Investigative Dermatology. 138, 4, p. 731-734 4 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

View all (55) »

View graph of relations

ID: 209317